Literature DB >> 20106602

Low level nicotine: a novel approach to reduce osteoporosis incidence.

Jun Zhang1, Feng Chen, Feng Yun, Jinping Chen.   

Abstract

Osteoporosis is a serious health problem worldwide and leads to a significant burden on society. Unfortunately, efforts to control osteoporosis are largely unsuccessful. Lowering an individual's risk for osteoporosis must focus not only on treatment but also on modification of risk factors. One of the common risk factors is smoking tobacco. Here, we review the clinical evidence on nicotine consumption and osteoporosis, and propose a possible protective mechanism. It should be note that there is no strong clinical evidence that proves nicotine is detrimental. Studies also indicated that the prime criminal for osteoporosis is smoking not nicotine. Moreover, low level nicotine has preventive efforts on osteoporosis by stimulating osteoblasts proliferation and differentiation. We present a hypothesis that low level nicotine may be a novel approach to reduce osteoporosis incidence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20106602     DOI: 10.1016/j.mehy.2009.12.024

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Nicotine Increases Osteoblast Activity of Induced Bone Marrow Stromal Cells in a Dose-Dependent Manner: An in vitro Cell Culture Experiment.

Authors:  Scott D Daffner; Stacey Waugh; Timothy L Norman; Nilay Mukherjee; John C France
Journal:  Global Spine J       Date:  2012-09

2.  Predicting and Exploring the Mechanisms of Erzhi Pill in Prevention and Treatment of Osteoporosis Based on Network Pharmacology and Zebrafish Experiments.

Authors:  Zhiguo Zhong; Yuyun Li; Yan Chen; Wen Chen; Siyan Li; Xiaohua Lv; Shiying Luo
Journal:  Drug Des Devel Ther       Date:  2021-02-24       Impact factor: 4.162

3.  Effects of sex, tobacco smoking, and alcohol consumption osteoporosis development: Evidence from Taiwan biobank participants.

Authors:  Chung-Yuan Yang; Jerry Cheng-Yen Lai; Wei-Lun Huang; Chiao-Lin Hsu; Shaw-Ji Chen
Journal:  Tob Induc Dis       Date:  2021-06-17       Impact factor: 2.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.